Press Releases
-
First among South Korea’s clinical trial sample analysis institutions, SK bioscience implements a La...2023.09.20
-
-Ana Brnabi?, Prime Minister of Serbia visited the SK bioscience headquarters.-SK bioscience signed ...2023.09.08
-
-SK bioscience and Vaxxas have officially entered into a Joint Development Agreement. This collabora...2023.08.24
-
-SKYCellflu, the world’s first cell culture-based influenza vaccine obtaining WHO’s PQ, will be deli...2023.08.23
-
-SK bioscience makes a strategic equity investment in Novavax to respond to the endemic situation an...2023.08.09
-
SK bioscience donated to support the local community where L House, SK bioscience’s vaccine manufact...2023.07.31
-
SK bioscience identified 11 top-priority issues by adopting Double Materiality Assessment. Company e...2023.07.28
-
-Jaeyong Ahn, the CEO of SK bioscience, virtually joined the WHO workshop with representatives of gl...2023.07.13
-
SK bioscience and the Government Pharmaceutical Organization agreed to establish a pandemic response...2023. 07. 05
-
-The 21-valent pneumococcal conjugate vaccine candidate, GBP410 (also known as SP0202), demonstrates...2023.06.30
-
SK bioscience will collaborate with one of the world’s leading biomedical research institutes, the P...2023.06.27
-
- In a Phase III trial, the vaccine demonstrated neutralizing antibody responses against SARS-CoV-2 ...2023.06.19